A validated assay for the quantitative analysis of vatalanib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-11-01
著者
-
Schellens J
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Rosing H
Netherlands Cancer Inst. Amsterdam Nld
-
Rosing H.
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Rosing H.
Dept. Of Pharmacy And Pharmacology Slotervaart Hospital/netherlands Cancer Institute
-
Rosing H.
Department Of Pharmacy Slotervaart Hospital
-
Beijnen J.
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Beijnen J.
Department Of Medical Oncology The Netherlands Cancer Institute/antoni Van Leeuwenhoek Huis
-
Huitema A.
Slotervaart Hospital Department Of Pharmacy & Pharmacology
-
Huitema A.
Department Of Pharmacy And Pharmacology Slotervaart Hospital
-
Schellens J.
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Schellens J.
Department Of Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherlands Cancer Institute
-
Rosing H.
Department Of Pharmacy & Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Hillebrand M.
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
LANKHEET A.
Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
LANGENBERG M.
Department of Medical Oncology, University Medical Center Utrecht
-
VOEST E.
Department of Medical Oncology, University Medical Center Utrecht
-
SCHELLENS J.
Beta Faculty, Department of Pharmaceutical Sciences, Division of Biomedical Analysis, Utrecht Univer
-
Voest E.
Department Of Medical Oncology University Medical Center Utrecht
-
Lankheet A.
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Langenberg M.
Department Of Medical Oncology University Medical Center Utrecht
関連論文
- Quantitative and selective assay of 5-methylindirubine, an inhibitor of cyclin-dependent kinases, in murine plasma using coupled liquid chromatography and electrospray tandem mass spectrometry
- Bio-analysis of docetaxel and hydroxylated metabolites in human plasma by high-performance liquid chromatography and automated solid-phase extraction
- High-performance liquid chromatographic procedures for the quantitative determination of paclitaxel (Taxol) in human urine
- Development and validation of a quantitative assay for the measurement of two HIV-fusion inhibitors, enfuvirtide and tifuvirtide, and one metabolite of enfuvirtide (M-20) in human plasma by liquid chromatography-tandem mass spectrometry
- Enzymatic digestion as a tool for the LC-MS/MS quantification of large peptides in biological matrices : Measurement of chymotryptic fragments from the HIV-1 fusion inhibitor enfuvirtide and its metabolite M-20 in human plasma
- High-performance liquid chromatographic analysis for the determination of a novel polymer-bound camptothecin derivative (MAG-camptothecin) and free camptothecin in human plasma
- Liquid chromatography-tandem mass spectrometric assays for salinomycin in mouse plasma, liver brain and small intestinal contents and in OptiMEM cell culture medium
- Liquid chromatography-tandem mass spectrometric assay for the analysis of uracil, 5,6-dihydrouracil and β-ureidopropionic acid in urine for the measurement of the activities of the pyrimidine catabolic enzymes
- Liquid chromatographic assay for the antiviral nucleotide analogue tenofovir in plasma using derivatization with chloroacetaldehyde
- Bioanalysis and preliminary pharmacokinetics of the acridonecarboxamide derivative GF120918 in plasma of mice and humans by ion-pairing reversed-phase high-performance liquid chromatography with fluorescence detection
- Analysis of Ecteinascidin 743, a new potent marine-derived anticancer drug, in human plasma by high-performance liquid chromatography in combination with solid-phase extraction
- Quantification of topotecan and its metabolite N-desmethyltopotecan in human plasma, urine and faeces by high-performance liquid chromatographic methods
- Quantification of paclitaxel metabolites in human plasma by high-performance liquid chromatography
- Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection
- Review on the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and its phase I and phase II metabolites in biological matrices, foodstuff and beverages
- Liquid chromatography-tandem mass spectrometric assay for pravastatin and two isomeric metabolites in mouse plasma and tissue homogenates
- Validation of a quantitative assay for human neutrophil peptide-1, -2, and -3 in human plasma and serum by liquid chromatography coupled to tandem mass spectrometry
- High-performance liquid chromatographic determination of the novel antitumour drug topotecan and topotecan as the total of the lactone plus carboxylate forms, in human plasma
- Development and validation of a liquid chromatography-tandem mass spectrometry assay for the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its metabolite 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in plasma
- Liquid chromatography-tandem mass spectrometric assay for clobetasol propionate in human serum from patients with atopic dermatitis
- Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry
- Liquid chromatography-tandem mass spectrometric assay for the light sensitive tyrosine kinase inhibitor axitinib in human plasma
- A validated assay for the quantitative analysis of vatalanib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry
- Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry
- Liquid chromatography-tandem mass spectrometric assay for sorafenib and sorafenib-glucuronide in mouse plasma and liver homogenate and identification of the glucuronide metabolite
- Liquid chromatography-tandem mass spectrometric assay for diclofenac and three primary metabolites in mouse plasma
- Quantitative bioanalysis of peptides by liquid chromatography coupled to (tandem) mass spectrometry
- A sensitive assay for the quantitative analysis of vinorelbine in mouse and human EDTA plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry
- High-performance liquid chromatographic determination of the antifungal drug fluconazole in plasma and saliva of human immunodeficiency virus-infected patients
- Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatograph coupled with tandem mass spectrometry
- Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometry
- Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry
- A sensitive LC-MS/MS method for the quantitative analysis of the Echinacea purpurea constituent undeca-2-ene-8,10-diynoic acid isobutylamide in human plasma
- Analytical procedure for the determination of the new antitumour drug N-benzoylstaurosporine and three potential metabolites in human plasma by reversed-phase high-performance liquid chromatography